Mathieu Boudreau Email and Phone Number
Mathieu Boudreau work email
- Valid
- Valid
- Valid
Mathieu Boudreau personal email
- Valid
Pragmatic, flexible and hands-on business development executive with broad experience including technology and product in-licensing/out-licensing, mergers & acquisitions, business/corporate strategy, venture creation and operations.Broad experience across transaction lifecycle, including deal sourcing, product evaluation, deal structuring and negotiation, deal implementation, alliance management and terminations.Business development experience and expertise spanning early stage and late stage development products as well as commercial stage opportunities across multiple therapeutic areas including oncology, immunology, urology, GI, respiratory, cardiometabolic, neurology, pain and other specialty areas.Focused on translating "transformational" science into business and commercial opportunities, acting as a key catalyst in the path leading to new medicines.
Foresee Pharmaceuticals
View-
Chief Business Officer And Chief Operating OfficerForesee Pharmaceuticals Jan 2024 - PresentTaipei, Tw
-
Chief Business OfficerForesee Pharmaceuticals Mar 2022 - Jan 2024Taipei, TwAs Chief Business Officer and member of the Foresee executive team, I play a leading role in architecting, implementing and executing Foresee’s corporate vision and strategy, seeking to sculpt an optimal path forward, utilizing creative approaches to growth, value creation and problem solving, always in concert with key stakeholders and in an environment of trust and camaraderie.
-
Vice President, Business DevelopmentForesee Pharmaceuticals Jan 2017 - Mar 2022Taipei, TwAs Vice President of Business Development and member of the Foresee executive team, I play a leading role in architecting, implementing and executing Foresee’s corporate business development/licensing strategy, with a focus on fostering partnerships and collaborations, leveraging Foresee’s product pipeline, namely its transformative early stage clinical and preclinical first-in-class programs targeting immune-fibrotic and mitochondrial-mediated lung diseases, cardiometabolic diseases and several rare diseases. As well as its NDA/EMA submission stage prostate cancer drug.
-
Vice President, Corporate Development & LicensingTelesta Therapeutics Inc. Apr 2014 - Dec 2016Belleville, On, CaAs head of Corporate Development & Licensing, part of the new leadership team, I played a leading role in shaping Telesta, implementing and executing corporate development strategy, with a focus on bringing to the market (through US commercial infrastructure and through partnerships) its lead MCNA Phase 3 bladder cancer product, for which a BLA was submitted to the U.S. FDA, accepted for filing by the FDA and designated for Priority Review with a PDUFA date of February 27, 2016. While at Telesa I led several strategic transactions, including a significant license agreement for its Phase 3 uro-oncology program with global specialty pharmaceutical company, Ipsen. -
Director, Business Development & Strategic PlanningPharmascience Jun 2011 - Apr 2014Montreal, Quebec, CaResponsible for the business strategy and executing the business development plan for the Discovery Research and Innovative Drug Development Group within Scientific Affairs. This includes responsibility for out-licensing, in-licensing, exploring and implementing innovative R&D financing and partnership models related to the early stage drug candidate portfolio emerging from the discovery research group. -
Director, Search & Evaluation - Business DevelopmentPendopharm Jun 2011 - Apr 2014Montreal, Québec, CaPart of the business development team responsible for the identification/sourcing, preliminary evaluation and negotiation of late stage/commercial product in-licensing/acquisition opportunities in the areas of Urology, Oncology, Gastroenterology and Acute Care/Hospital. -
Director, Business DevelopmentAegera Therapeutics Inc. May 2005 - Jun 2011CaAegera Therapeutics Inc. was acquired by Pharmascience Inc. in May 2011. Aegera was focused on the discovery of first-in-class/best-in-class small molecule therapeutics targeting innate immune, co-stimulatory and apoptotic signaling in oncology, immunology and neurology, with programs from discovery through Phase 2. Several significant partnerships/licenses were established over the years. -
Co-Founder & Head Of Business DevelopmentStart-Up Medical Device & Diagnostics Company May 2000 - Apr 2005
Mathieu Boudreau Skills
Mathieu Boudreau Education Details
-
Mcgill UniversityNeuroscience -
Université De MontréalBiochemistry
Frequently Asked Questions about Mathieu Boudreau
What company does Mathieu Boudreau work for?
Mathieu Boudreau works for Foresee Pharmaceuticals
What is Mathieu Boudreau's role at the current company?
Mathieu Boudreau's current role is CBO/COO at Foresee Pharmaceuticals | Biopharma Business-Science Catalyst.
What is Mathieu Boudreau's email address?
Mathieu Boudreau's email address is ma****@****ics.com
What schools did Mathieu Boudreau attend?
Mathieu Boudreau attended Mcgill University, Université De Montréal.
What skills is Mathieu Boudreau known for?
Mathieu Boudreau has skills like Biotechnology, Strategic Alliances, Pharmaceutical Industry, Strategy, Drug Discovery, Business Development, In/out Licensing, Licensing Negotiations, Deal Sourcing, Licensing Strategy, Business Strategy, Deal Structures.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial